关节镜联合径向体外冲击波治疗距骨骨软骨炎的有效性与安全性:一项前瞻性单中心随机双盲研究
该前瞻性单中心随机双盲安慰剂对照试验纳入40例距骨骨软骨炎患者,比较关节镜微骨折联合径向体外冲击波治疗(rESWT)与单纯微骨折的疗效。rESWT组术后3周接受冲击波治疗,隔日一次共5次。结果显示rESWT组术后3、6、12个月AOFAS评分显著更高、VAS疼痛评分显著更低,术后6、12个月骨髓水肿面积显著更小,随访12个月无并发症。
要点
- rESWT组术后3、6、12个月AOFAS评分显著高于对照组(p<0.05)。
- rESWT组术后3、6、12个月VAS疼痛评分显著低于对照组(p<0.05)。
- rESWT组术后6、12个月骨髓水肿面积显著小于对照组(p<0.05)。
核心结论
- 局部冲击波治疗对接受关节镜手术联合rESWT治疗的距骨骨软骨炎患者安全有效。
- 初步结果显示,与单纯关节镜微骨折相比,关节镜微骨折联合rESWT的患者术后3个月疼痛缓解更好,踝关节负重和运动功能改善。
研究设计与样本
- 前瞻性单中心随机双盲安慰剂对照试验,纳入40例距骨骨软骨炎患者,随机分为rESWT组和对照组各20例。
- rESWT组术后3周接受冲击波治疗,隔日一次共5次;对照组设备治疗头无能量输出。
- 主要结局指标为美国足踝外科协会(AOFAS)踝-后足量表,次要结局包括疼痛视觉模拟评分(VAS)和矢状位脂肪抑制序列MRI显示的距骨骨髓水肿面积。
- 评估时间点为术前及术后6周、3个月、6个月、12个月。
主要发现
- 两组基线特征无统计学显著差异。
- 随访12个月期间未发现伤口感染或神经血管损伤等并发症。
- rESWT组术后3、6、12个月平均AOFAS评分显著高于对照组(p<0.05)。
- rESWT组术后3、6、12个月平均VAS疼痛评分显著低于对照组(p<0.05)。
- rESWT组术后6、12个月平均骨髓水肿面积显著小于对照组(p<0.05)。
临床怎么用
- 原文结论未据此给出具体推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
AIMS: Arthroscopic microfracture is a conventional form of treatment for patients with osteochondritis of the talus, involving an area of < 1.5 cm2. However, some patients have persistent pain and limitation of movement in the early postoperative period. No studies have investigated the combined treatment of microfracture and shortwave treatment in these patients. The aim of this prospective single-centre, randomized, double-blind, placebo-controlled trial was to compare the outcome in patients treated with arthroscopic microfracture combined with radial extracorporeal shockwave therapy (rESWT) and arthroscopic microfracture alone, in patients with ostechondritis of the talus. METHODS: Patients were randomly enrolled into two groups. At three weeks postoperatively, the rESWT group was given shockwave treatment, once every other day, for five treatments. In the control group the head of the device which delivered the treatment had no energy output. The two groups were evaluated before surgery and at six weeks and three, six and 12 months postoperatively. The primary outcome measure was the American Orthopaedic Foot and Ankle Society (AOFAS) Ankle-Hindfoot Scale. Secondary outcome measures included a visual analogue scale (VAS) score for pain and the area of bone marrow oedema of the talus as identified on sagittal fat suppression sequence MRI scans. RESULTS: A total of 40 patients were enrolled and randomly divided into the two groups, with 20 in each. There was no statistically significant difference in the baseline characteristics of the groups. No complications, such as wound infection or neurovascular injury, were found during follow-up of 12 months. The mean AOFAS scores in the rESWT group were significantly higher than those in the control group at three, six, and 12 months postoperatively (p < 0.05). The mean VAS pain scores in the rESWT group were also significantly lower than those in the control group at these times (p < 0.05). The mean area of bone marrow oedema in the rESWT group was significantly smaller at six and 12 months than in the control group at these times (p < 0.05). CONCLUSION: Local shockwave therapy was safe and effective in patients with osteochondiritis of the talus who were treated with a combination of arthroscopic surgery and rESWT. Preliminary results showed that, compared with arthroscopic microfracture alone, those treated with arthroscopic microfracture combined with rESWT had better relief of pain at three months postoperatively and improved weightbearing and motor function of the ankle.
引用
- Cao J, Zhang C, Huang H, et al. Effectiveness and safety of arthroscopy combined with radial extracorporeal shockwave therapy for osteochondritis of the talus: a prospective, single-centre, randomized, double-blind study. Bone Joint J. 2023. PMID: 37777205. doi:10.1302/0301-620X.105B10.BJJ-2023-0152.R2
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。